Abraham van den Ende
Abraham van den Ende publishes mostly in Endocrinology, Diabetes and Metabolism, Hematology and Surgery, on topics such as Hormonal and reproductive studies, Blood Coagulation and Thrombosis Mechanisms and Lipoproteins and Cardiovascular Health.
- World rank
- #1,735,890 of 7,710,434 ranked researchers
- Rank in Netherlands
- #38,425 of 107,149
- Works
- 54
- Citations
- 1.7k
- Citations per work
- 31.9
What does Abraham van den Ende research?
Abraham van den Ende's work is mostly in Medicine (30%), Immunology and Microbiology (5%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3361.2%
- Health Sciences1630.2%
- Medicine1630.2%
- Life Sciences58.6%
- 1Endocrinology, Diabetes and Metabolism12% of their works
- 2Hematology8% of their works
- 3Surgery6% of their works
- 4Immunology5% of their works
- 5Pulmonary and Respiratory Medicine4% of their works
- 6Biochemistry3% of their works
Research topics
- Hormonal and reproductive studies
- Blood Coagulation and Thrombosis Mechanisms
- Lipoproteins and Cardiovascular Health
- Venous Thromboembolism Diagnosis and Management
- Amino Acid Enzymes and Metabolism
- Sexual Differentiation and Disorders
- Blood transfusion and management
- Diabetes, Cardiovascular Risks, and Lipoproteins
Which keywords describe Abraham van den Ende's research?
The keywords of their largest research topics: Diabetes, Metabolic Syndrome, Antithrombotic Therapy, Hormone Therapy, Testosterone, Genetic Variants, Cholesterol-lowering and Protease-Activated Receptors.
- Steroid 21-Hydroxylase Deficiency
- Hemorrhage
- Congenital Adrenal Hyperplasia
- Blood Transfusion
- Venous Thromboembolism
- Thrombin
- Protease-Activated Receptors
- Genetic Variants
- Hormone Therapy
- Metabolic Syndrome
- Diabetes
- Antithrombotic Therapy
- Testosterone
- Cholesterol-lowering
- Statins
- Pulmonary Embolism
- Amino Acid Transporters
- Cardiovascular Disease
- D-Serine
- Insulin Resistance
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Diabetes132 topics
- Metabolic Syndrome132 topics
- Antithrombotic Therapy102 topics
- Hormone Therapy101 topic
- Testosterone101 topic
- Genetic Variants92 topics
- Cholesterol-lowering61 topic
- Protease-Activated Receptors61 topic
- Statins61 topic
- Thrombin61 topic
- Pulmonary Embolism41 topic
- Venous Thromboembolism41 topic
- Amino Acid Transporters31 topic
- Blood Transfusion31 topic
- Cardiovascular Disease31 topic
- Congenital Adrenal Hyperplasia31 topic
- D-Serine31 topic
- Hemorrhage31 topic
- Insulin Resistance31 topic
- Steroid 21-Hydroxylase Deficiency31 topic
Where does Abraham van den Ende work?
Abraham van den Ende's main affiliation in the publication record is Slotervaartziekenhuis, Netherlands.
How many publications and citations does Abraham van den Ende have?
OpenAlex counts 54 works and 1,722 citations for Abraham van den Ende, an h-index of 18, ranking #1,735,890 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Abraham van den Ende. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.